|
RNF10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67998948086279E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62914126633495E-12 |
| Normal-vs-Stage2 |
8.53379999998793E-09 |
| Normal-vs-Stage3 |
2.11409999995027E-06 |
| Normal-vs-Stage4 |
1.801620E-01 |
| Stage1-vs-Stage2 |
9.116200E-01 |
| Stage1-vs-Stage3 |
3.193900E-02 |
| Stage1-vs-Stage4 |
1.266030E-01 |
| Stage2-vs-Stage3 |
1.211420E-01 |
| Stage2-vs-Stage4 |
1.475410E-01 |
| Stage3-vs-Stage4 |
4.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62880819942757E-12 |
| Normal-vs-AfricanAmerican |
1.80649999959037E-07 |
| Normal-vs-Asian |
1.798400E-01 |
| Caucasian-vs-AfricanAmerican |
2.806300E-02 |
| Caucasian-vs-Asian |
5.158000E-01 |
| AfricanAmerican-vs-Asian |
7.603200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62936331093988E-12 |
| Normal-vs-Female |
2.88720000130027E-08 |
| Male-vs-Female |
2.168200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.47889994589679E-09 |
| Normal-vs-Extreme_Weight |
1.64857016926589E-12 |
| Normal-vs-Obese |
9.32580013213169E-10 |
| Normal-vs-Extreme_Obese |
5.8142999999955E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.591000E-01 |
| Normal_Weight-vs-Obese |
5.586800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.298600E-01 |
| Extreme_Weight-vs-Obese |
4.673900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.860600E-01 |
| Obese-vs-Extreme_Obese |
6.598200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.578900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.9322100303375E-12 |
| Normal-vs-Age(61-80Yrs) |
3.12305736827057E-13 |
| Normal-vs-Age(81-100Yrs) |
7.68210000057223E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.966200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.887980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.638000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.554400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.909370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.402000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66078262253677E-12 |
| Normal-VS-Type2 PRCC |
4.05170341721828E-11 |
| Normal-VS-KIRP CIMP |
4.117600E-01 |
| Normal-VS-Unclassified PRCC |
7.58360000352454E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.390000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.388430E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.599600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.788900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.779800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.204700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.28049792991192E-11 |
| Normal-vs-N1 |
2.437500E-03 |
| Normal-vs-N2 |
9.333800E-02 |
| N0-vs-N1 |
1.578530E-03 |
| N0-vs-N2 |
1.380040E-01 |
| N1-vs-N2 |
9.112600E-01 |
|
|
